Beranda › Melanoma › Georgia › Atlanta
Uji klinis Melanoma di Atlanta, GA
21 studi untuk Melanoma mencari peserta di lokasi sekitar Atlanta (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Winship Cancer Institute of Emory University, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Atlanta VA Medical Center, Decatur · 6 mi jauhnya
Pan-tumor MRD Study
Menerima pesertaStudi observasional
- Piedmont Cancer Institute, Atlanta
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Menerima pesertaFase 3
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Menerima pesertaFase 2
- Emory University - Winship Cancer Institute, Atlanta
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Menerima pesertaFase 1/2
- Emory University, Atlanta
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Menerima pesertaFase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
- Winship Cancer Institute - Emory University, Atlanta
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 2
- USA10-0, Atlanta
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Menerima pesertaFase 1/2
- Piedmont Healthcare, Atlanta
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Menerima pesertaFase 2/3
- Emory Winship Cancer Institute, Atlanta
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Northside Hospital, Atlanta
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Menerima pesertaFase 3
- Winship Cancer Institute of Emory University, Atlanta
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Menerima pesertaFase 3
- Winship Cancer Institute, Emory university, Atlanta
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Research Site 114, Atlanta
- Research Site 139, Atlanta
Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
Menerima pesertaFase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Atlanta
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Menerima peserta
- Emory University, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
Menerima pesertaFase 1/2
- Emory - Winship Cancer Institute, Atlanta
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Emory University Hospital Midtown, Atlanta
- Emory University, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
- dan 2 lainnya
Uji klinis Melanoma di kota lain
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN33 studi
- Pittsburgh, PA31 studi
- Boston, MA26 studi
- Philadelphia, PA23 studi
- San Francisco, CA22 studi
- Durham, NC21 studi
- St. Louis, MO21 studi
- Columbus, OH21 studi
- Salt Lake City, UT21 studi
Studi lain di Atlanta
- Kanker (semua jenis)49 studi
- Kanker Paru Non-Sel Kecil47 studi
- Kanker Payudara41 studi
- Mieloma Multipel41 studi
- Kanker Prostat33 studi
- Leukemia Mieloid Akut30 studi
- Kanker Ovarium29 studi
- Kanker Paru29 studi
- Kanker Kolorektal29 studi
- Kanker Metastatik28 studi
- Gagal Jantung25 studi
- Gangguan Depresi Mayor25 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.